Alkem Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 27,999.9 million compared to INR 23,628 million a year ago. Revenue was INR 28,419.5 million compared to INR 23,983.4 million a year ago. Net income was INR 5,442.6 million compared to INR 4,720.6 million a year ago. Basic earnings per share from continuing operations was INR 45.52 compared to INR 39.48 a year ago. Diluted earnings per share from continuing operations was INR 45.52 compared to INR 39.48 a year ago. For the six months, sales was INR 55,313.5 million compared to INR 43,548 million a year ago. Revenue was INR 56,199.6 million compared to INR 44,453.3 million a year ago. Net income was INR 10,123.8 million compared to INR 8,940.7 million a year ago. Basic earnings per share from continuing operations was INR 84.67 compared to INR 74.78 a year ago. Diluted earnings per share from continuing operations was INR 84.67 compared to INR 74.78 a year ago.